Serum and lymphocytic neurotrophins profiles in systemic lupus erythematosus: a case-control study.
<h4>Background</h4>Neurotrophins play a central role in the development and maintenance of the nervous system. However, neurotrophins can also modulate B and T cell proliferation and activation, especially via autocrine loops. We hypothesized that both serum and lymphocytic neurotrophin...
Guardado en:
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2013
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/9161b371283d47b7b289f5bd74c99113 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:9161b371283d47b7b289f5bd74c99113 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:9161b371283d47b7b289f5bd74c991132021-11-18T08:48:40ZSerum and lymphocytic neurotrophins profiles in systemic lupus erythematosus: a case-control study.1932-620310.1371/journal.pone.0079414https://doaj.org/article/9161b371283d47b7b289f5bd74c991132013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24223945/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Neurotrophins play a central role in the development and maintenance of the nervous system. However, neurotrophins can also modulate B and T cell proliferation and activation, especially via autocrine loops. We hypothesized that both serum and lymphocytic neurotrophin levels may be deregulated in systemic Lupus erythematosus (SLE) and may reflect clinical symptoms of the disease.<h4>Methods</h4>Neurotrophins in the serum (ELISA tests) and lymphocytes (flow cytometry) were measured in 26 SLE patients and 26 control subjects. Th1 (interferon-γ) and Th2 (IL-10) profiles and serum concentration of BAFF were assessed by ELISA in the SLE and control subjects.<h4>Findings</h4>We have demonstrated that both NGF and BDNF serum levels are higher in SLE patients than healthy controls (p=0.003 and p<0.001), independently of Th1 or Th2 profiles. Enhanced serum NT-3 levels (p=0.003) were only found in severe lupus flares (i.e. SLEDAI ≥ 10) and significantly correlated with complement activation (decreased CH 50, Γ=-0.28, p=0.03). Furthermore, there was a negative correlation between serum NGF levels and the number of circulating T regulatory cells (Γ=0.48, p=0.01). In circulating B cells, production of both NGF and BDNF was greater in SLE patients than in healthy controls. In particular, the number of NGF-secreting B cells correlated with decreased complement levels (p=0.05). One month after SLE flare treatment, BDNF levels decreased; in contrast, NGF and NT-3 levels remained unchanged.<h4>Conclusion</h4>This study demonstrates that serum and B cell levels of both NGF and BDNF are increased in SLE, suggesting that the neurotrophin production pathway is deregulated in this disease. These results must be confirmed in a larger study with naive SLE patients, in order to avoid the potential confounding influence of prior immune-modulating treatments on neurotrophin levels.Anne-Laure FauchaisMarie-Claude LisePierre MargetFrançois-Xavier LapeybieHoly BezanaharyClothilde MartelStéphanie DumonteilAgnès SparsaFabrice LallouéKim LyMarie EssigElisabeth VidalMarie-Odile JauberteauPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 11, p e79414 (2013) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Anne-Laure Fauchais Marie-Claude Lise Pierre Marget François-Xavier Lapeybie Holy Bezanahary Clothilde Martel Stéphanie Dumonteil Agnès Sparsa Fabrice Lalloué Kim Ly Marie Essig Elisabeth Vidal Marie-Odile Jauberteau Serum and lymphocytic neurotrophins profiles in systemic lupus erythematosus: a case-control study. |
| description |
<h4>Background</h4>Neurotrophins play a central role in the development and maintenance of the nervous system. However, neurotrophins can also modulate B and T cell proliferation and activation, especially via autocrine loops. We hypothesized that both serum and lymphocytic neurotrophin levels may be deregulated in systemic Lupus erythematosus (SLE) and may reflect clinical symptoms of the disease.<h4>Methods</h4>Neurotrophins in the serum (ELISA tests) and lymphocytes (flow cytometry) were measured in 26 SLE patients and 26 control subjects. Th1 (interferon-γ) and Th2 (IL-10) profiles and serum concentration of BAFF were assessed by ELISA in the SLE and control subjects.<h4>Findings</h4>We have demonstrated that both NGF and BDNF serum levels are higher in SLE patients than healthy controls (p=0.003 and p<0.001), independently of Th1 or Th2 profiles. Enhanced serum NT-3 levels (p=0.003) were only found in severe lupus flares (i.e. SLEDAI ≥ 10) and significantly correlated with complement activation (decreased CH 50, Γ=-0.28, p=0.03). Furthermore, there was a negative correlation between serum NGF levels and the number of circulating T regulatory cells (Γ=0.48, p=0.01). In circulating B cells, production of both NGF and BDNF was greater in SLE patients than in healthy controls. In particular, the number of NGF-secreting B cells correlated with decreased complement levels (p=0.05). One month after SLE flare treatment, BDNF levels decreased; in contrast, NGF and NT-3 levels remained unchanged.<h4>Conclusion</h4>This study demonstrates that serum and B cell levels of both NGF and BDNF are increased in SLE, suggesting that the neurotrophin production pathway is deregulated in this disease. These results must be confirmed in a larger study with naive SLE patients, in order to avoid the potential confounding influence of prior immune-modulating treatments on neurotrophin levels. |
| format |
article |
| author |
Anne-Laure Fauchais Marie-Claude Lise Pierre Marget François-Xavier Lapeybie Holy Bezanahary Clothilde Martel Stéphanie Dumonteil Agnès Sparsa Fabrice Lalloué Kim Ly Marie Essig Elisabeth Vidal Marie-Odile Jauberteau |
| author_facet |
Anne-Laure Fauchais Marie-Claude Lise Pierre Marget François-Xavier Lapeybie Holy Bezanahary Clothilde Martel Stéphanie Dumonteil Agnès Sparsa Fabrice Lalloué Kim Ly Marie Essig Elisabeth Vidal Marie-Odile Jauberteau |
| author_sort |
Anne-Laure Fauchais |
| title |
Serum and lymphocytic neurotrophins profiles in systemic lupus erythematosus: a case-control study. |
| title_short |
Serum and lymphocytic neurotrophins profiles in systemic lupus erythematosus: a case-control study. |
| title_full |
Serum and lymphocytic neurotrophins profiles in systemic lupus erythematosus: a case-control study. |
| title_fullStr |
Serum and lymphocytic neurotrophins profiles in systemic lupus erythematosus: a case-control study. |
| title_full_unstemmed |
Serum and lymphocytic neurotrophins profiles in systemic lupus erythematosus: a case-control study. |
| title_sort |
serum and lymphocytic neurotrophins profiles in systemic lupus erythematosus: a case-control study. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2013 |
| url |
https://doaj.org/article/9161b371283d47b7b289f5bd74c99113 |
| work_keys_str_mv |
AT annelaurefauchais serumandlymphocyticneurotrophinsprofilesinsystemiclupuserythematosusacasecontrolstudy AT marieclaudelise serumandlymphocyticneurotrophinsprofilesinsystemiclupuserythematosusacasecontrolstudy AT pierremarget serumandlymphocyticneurotrophinsprofilesinsystemiclupuserythematosusacasecontrolstudy AT francoisxavierlapeybie serumandlymphocyticneurotrophinsprofilesinsystemiclupuserythematosusacasecontrolstudy AT holybezanahary serumandlymphocyticneurotrophinsprofilesinsystemiclupuserythematosusacasecontrolstudy AT clothildemartel serumandlymphocyticneurotrophinsprofilesinsystemiclupuserythematosusacasecontrolstudy AT stephaniedumonteil serumandlymphocyticneurotrophinsprofilesinsystemiclupuserythematosusacasecontrolstudy AT agnessparsa serumandlymphocyticneurotrophinsprofilesinsystemiclupuserythematosusacasecontrolstudy AT fabricelalloue serumandlymphocyticneurotrophinsprofilesinsystemiclupuserythematosusacasecontrolstudy AT kimly serumandlymphocyticneurotrophinsprofilesinsystemiclupuserythematosusacasecontrolstudy AT marieessig serumandlymphocyticneurotrophinsprofilesinsystemiclupuserythematosusacasecontrolstudy AT elisabethvidal serumandlymphocyticneurotrophinsprofilesinsystemiclupuserythematosusacasecontrolstudy AT marieodilejauberteau serumandlymphocyticneurotrophinsprofilesinsystemiclupuserythematosusacasecontrolstudy |
| _version_ |
1718421275346468864 |